AGPU NASDAQ
Credit Risk of going bust: higher than 84% of companies Debt: 1.8% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.02 (down 99.7%), Axe Compute Inc. would be worth roughly what it owes.
Total debt $1.7M against a stock market value of $91.0M.
Distance to default 2.29 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $414K (short-term plus half of long-term), stock volatility 173.3%; Altman Z'' -28.67. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Pittsburgh, PA 15201
US
Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Zhu Theodore | A-Award | 733 | — | 2026-10-01 |
| Nuzum Charles Lee Sr | A-Award | 733 | — | 2026-10-01 |
| Hawryluk Matthew | A-Award | 733 | — | 2026-10-01 |
| HANDLEY DANIEL E | A-Award | 528 | — | 2026-10-01 |
| Dirks Thorsten | A-Award | 733 | — | 2026-10-01 |